Study Stopped
no patients found
Screening for Obstructive Sleep Apnea in Medical Patients
1 other identifier
observational
N/A
1 country
2
Brief Summary
Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences. Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
August 8, 2023
CompletedStudy Start
First participant enrolled
October 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2025
CompletedFebruary 25, 2025
February 1, 2025
1.3 years
July 20, 2023
February 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants who are found to have obstructive sleep apnea
Those who are found to have symptoms of OSA will be referred for further evaluation to get the final diagnosis of OSA
From date of study enrollment until the date of first documented diagnosis of obstructive sleep apnea, assessed up to 4 weeks.
Interventions
Patient will be interviewed and asked of there are symptoms of snoring, day somnolence, chocking or gasping during sleep
Eligibility Criteria
Patients without known OSA who are admitted to the general medical ward will be Screened for signs and symptoms of OSA by answering the questions that have the statement :Do you have...?". The symptoms include snoring, day time somnolesce, sudden chocking or gasping during sleep..
You may qualify if:
- Willing to sign an informed consent
- Patient is admitted to the medical ward in a tertiary hospital
You may not qualify if:
- Patients known to have obstructive sleep apnea.
- Patients younger than 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ayman Hammoudeh
Amman, 11184, Jordan
Istishari Hospital
Amman, 11888, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2023
First Posted
August 8, 2023
Study Start
October 15, 2023
Primary Completion
February 15, 2025
Study Completion
February 22, 2025
Last Updated
February 25, 2025
Record last verified: 2025-02